Scientific Advisory Board
The governance of HudsonAlpha is carried out through the actions of two boards, the board of directors and the scientific advisory board. The authority for maintaining the institute’s founding purpose and the determinations of all other scientific matters is vested in the HudsonAlpha Scientific Advisory Board.
A world-class research institute must have a world-class Scientific Advisory Board. Seven uniquely skilled and internationally known investigators have agreed to serve in this capacity.
Dr. Richard Myers
President and Director, HudsonAlpha Institute
Dr. Geoffrey Duyk
Partner/Managing Director TPG Biotech
Dr. Tom Hudson
President and Scientific Director, Ontario Institute for Cancer Research and Director, P3G (Public Population Project in Genomics)
Dr. Tom Maniatis
Isidore S. Edelman Professor and Chairman of the department of biochemistry and molecular biophysics, Columbia University Medical Center and co-founder, New York Genome Center
Dr. Val Sheffield
Howard Hughes Medical Investigator, and Director of the Division of Medical Genetics at the University of Iowa
Dr. Barbara Wold
Director of the Beckman Institute, and Professor of Molecular Biology, California Institute of Technology
In addition, the HudsonAlpha Institute for Biotechnology expects to appoint investigators whose research focus aligns with the overall institute goals. The institute would expect to expand on the research and findings gained by HudsonAlpha Institute for Biotechnology investigators to insure that products aimed at helping patients would be commercialized as rapidly as possible.
The director of the institute will oversee the selection process, with guidance from the scientific advisory board, associate companies and/or members of the board of directors.